Effects of the adenosine A1 receptor antagonist rolofylline on renal function

Journal of the American College of Cardiology

Volumn 57, Issue 19, 2011, Pages 1899-1907

  Voors, Adriaan A ^a   Dittrich, Howard C ^b   Massie, Barry M ^c   Delucca, Paul ^b   Mansoor, George A ^b   Metra, Marco ^d   Cotter, Gad ^e   Weatherley, Beth D ^e   Ponikowski, Piotr ^g   Teerlink, John R ^c   Cleland, John G F ^h   O'Connor, Christopher M ^f   Givertz, Michael M ⁱ  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF BRESCIA   (Italy)

^e Momentum Research Inc   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h UNIVERSITY OF HULL   (United Kingdom)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adenosine receptor antagonist; diuretics; heart failure; renal function; rolofylline

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; NATRIURETIC FACTOR; NITRATE; PLACEBO; ROLOFYLLINE; 1,3-DIPROPYL-8-(3-NORADAMANTYL)XANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; XANTHINE DERIVATIVE;

ACUTE HEART FAILURE; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMOFILTRATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPEREMIA; HYPERVOLEMIA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; WEIGHT REDUCTION; ACUTE DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART FAILURE; HEART STROKE VOLUME; KIDNEY; KIDNEY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; TREATMENT OUTCOME;

ACUTE DISEASE; ADENOSINE A1 RECEPTOR ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; PILOT PROJECTS; STROKE VOLUME; TREATMENT OUTCOME; XANTHINES;

EID: 79955653217     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.11.057     Document Type: Article

References (30)

1. J.T. Heywood, G.C. Fonarow, M.R. Costanzo ADHERE Scientific Advisory Committee and Investigators High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430 (Pubitemid 47179911)
2. H.M. Krumholz, Y.T. Chen, and V. Vaccarino Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure Am J Cardiol 85 2000 1110 1113 (Pubitemid 30214258)
3. M.R. Cowie, M. Komajda, T. Murray-Thomas, J. Underwood, B. Ticho POSH Investigators Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) Eur Heart J 27 2006 1216 1222
4. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients J Card Fail 12 2006 257 262
5. K. Damman, G. Navis, and A.A. Voors Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608 (Pubitemid 47513536)
6. K. Damman, T. Jaarsma, A.A. Voors COACH Investigators Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) Eur J Heart Fail 11 2009 847 854
7. C. Ronco, M. Haapio, A.A. House, N. Anavekar, and R. Bellomo Cardiorenal syndrome J Am Coll Cardiol 52 2008 1527 1539
8. G.C. Fonarow, and J.T. Heywood The confounding issue of comorbid renal insufficiency Am J Med 119 Suppl 1 2006 S17 S25
9. K.V. Liang, A.W. Williams, E.L. Greene, and M.M. Redfield Acute decompensated heart failure and the cardiorenal syndrome Crit Care Med 36 Suppl 1 2008 S75 S88
10. M.M. Dohadwala, and M.M. Givertz Role of adenosine antagonism in the cardiorenal syndrome Cardiovasc Ther 26 2008 276 286
11. S.S. Gottlieb, D.C. Brater, and I. Thomas BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy Circulation 105 2002 1348 1353 (Pubitemid 34260427)
12. H. Funaya, M. Kitakaze, K. Node, T. Minamino, K. Komamura, and M. Hori Plasma adenosine levels increase in patients with chronic heart failure Circulation 95 1997 1363 1365 (Pubitemid 27142790)
13. F. Franceschi, J.C. Deharo, and R. Giorgi Peripheral plasma adenosine release in patients with chronic heart failure Heart 95 2009 651 655
14. H.C. Dittrich, D.K. Gupta, T.C. Hack, T. Dowling, J. Callahan, and S. Thomson The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment J Card Fail 13 2007 609 617 (Pubitemid 47513547)
15. M.M. Givertz, B.M. Massie, T.K. Fields, L.L. Pearson, H.C. Dittrich CKI-201 and CKI-202 Investigators The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance J Am Coll Cardiol 50 2007 1551 1560 (Pubitemid 47532320)
16. G. Cotter, H.C. Dittrich, B.D. Weatherley PROTECT Steering Committee, Investigators, and Coordinators The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment J Card Fail 14 2008 631 640
17. B.M. Massie, C. O'Connor, M. Metra PROTECT Investigators and Committees Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
18. B.D. Weatherley, G. Cotter, H.C. Dittrich PROTECT Steering Committee, Investigators, and Coordinators Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function J Cardiac Fail 16 2010 25 35
19. G.L. Smith, V. Vaccarino, and M. Kosiborod Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9 2003 13 25 (Pubitemid 36356697)
20. M.W. Akhter, D. Aronson, and F. Bitar Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure Am J Cardiol 94 2004 957 960 (Pubitemid 39349569)
21. A. Nohria, V. Hasselblad, and A. Stebbins Cardiorenal interactions: insights from the ESCAPE trial J Am Coll Cardiol 51 2008 1268 1274 (Pubitemid 351400890)
22. S. Ljungman, J.H. Laragh, and R.J. Cody Role of the kidney in congestive heart failure Relationship of cardiac index to kidney function Drugs 39 Suppl 4 1990 10 21 (Pubitemid 20182861)
23. K. Damman, G. Navis, and T.D. Smilde Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J Heart Fail 9 2007 872 878 (Pubitemid 47332311)
24. K. Damman, V.M. van Deursen, G. Navis, A.A. Voors, D.J. van Veldhuisen, and H.L. Hillege Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease J Am Coll Cardiol 53 2009 582 588
25. W. Mullens, Z. Abrahams, and H.N. Skouri Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51 2008 300 306
26. W. Mullens, Z. Abrahams, and G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
27. U. Elkayam, A. Mehra, and G. Cohen Renal circulatory effects of adenosine in patients with chronic heart failure J Am Coll Cardiol 32 1998 211 215 (Pubitemid 28351064)
28. A. Edlund, H. Ohlsn, and A. Sollevi Renal effects of local infusion of adenosine in man Clin Sci (Lond) 87 1994 143 149 (Pubitemid 24267081)
29. B. Greenberg, I. Thomas, and D. Banish Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study J Am Coll Cardiol 50 2007 600 606 (Pubitemid 47198998)
30. Abraham WT. Results of the TRIDENT-1 trial: a phase 2b study to assess the safety and tolerability of IV tonapofylline in subjects with acute decompensated heart failure and renal insufficiency. Paper presented at: the European Society of Cardiology Heart Failure Congress, Late Breaking Clinical Trials; May 30, 2010; Berlin, Germany.